{"id":34751,"date":"2020-05-18T00:00:00","date_gmt":"2020-05-18T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2020\/05\/18\/experimental-covid-19-vaccine-appears-safe-triggers-immune-response\/"},"modified":"2020-05-19T16:10:08","modified_gmt":"2020-05-19T16:10:08","slug":"experimental-covid-19-vaccine-appears-safe-triggers-immune-response","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2020\/05\/18\/experimental-covid-19-vaccine-appears-safe-triggers-immune-response\/","title":{"rendered":"Experimental COVID-19 Vaccine Appears Safe, Triggers Immune Response"},"content":{"rendered":"<h3>Findings from early-stage trial that started in March and included eight healthy people receiving two doses<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>MONDAY, May 18, 2020 (HealthDay News) &#8212; An experimental vaccine against COVID-19 appears to be safe and to trigger an immune response, according to results of the first human clinical trial of a COVID-19 vaccine.<\/p>\n<p>The findings from the early-stage trial that started in March included eight healthy people who each received two doses of the vaccine, <i>The New York Times<\/i> reported.<\/p>\n<p>The volunteers made antibodies that were able to stop COVID-19 from replicating, and the levels of the antibodies were similar to those in people who have recovered after contracting the virus, according to vaccine maker Moderna.<\/p>\n<p>The company said the next phase of the testing will involve 600 people and is scheduled to begin soon, but U.S. officials have cautioned that it could take a year to 18 months to produce a vaccine that would be widely available, <i>The Times<\/i> reported.<\/p>\n<p><a href=\"https:\/\/www.nytimes.com\/2020\/05\/18\/health\/coronavirus-vaccine-moderna.html\" target=\"_new\" rel=\"noopener noreferrer\"><i>The New York Times<\/i> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Findings from early-stage trial that started in March and included eight healthy people receiving two doses<\/p>\n","protected":false},"author":6,"featured_media":34768,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-34751","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/34751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=34751"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/34751\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/34768"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=34751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=34751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=34751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}